Annual Drug Patent Expirations for AMITIZA
Amitiza is a drug marketed by Sucampo Pharma Llc and is included in one NDA. It is available from three suppliers. There are nine patents protecting this drug and one Paragraph IV challenge.
Drug patent litigation for AMITIZA.
This drug has one hundred and twenty-two patent family members in twenty-four countries.
The generic ingredient in AMITIZA is lubiprostone. Three suppliers are listed for this compound. Additional details are available on the lubiprostone profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
